FINWIRES · TerminalLIVE
FINWIRES

Haisco Pharmaceutical Gets China Nod for Analgesic Drug Trial; Shares Down 4%

By

Haisco Pharmaceutical (SHE:002653) obtained approval from China's drug regulator to conduct clinical trials for its HSK51155 tablets.

The oral drug candidate is being developed for the treatment of pain-related conditions, according to a filing with the Shenzhen bourse on Wednesday.

Shares of the company were down nearly 4% in recent trade.

Related Articles

Asia

Market Chatter: Mitsubishi Logistics Plans $40 Million Investment in Two New Distribution Centers in US

Mitsubishi Logistics (TYO:9301) plans to build two new distribution centers in Charlotte, North Carolina, and Houston, Texas, in the U.S. with an investment worth $40 million and later sell the assets, boosting returns on equity, Nikkei Asia reported Wednesday.The investments are part of a plan to expand the overseas real estate business of the company, with the completion of the centers scheduled for 2027, the report said.The new centers, located in the Sun Belt, will span 230,000 square feet in Charlotte and 710,000 square feet in Houston. The proceeds from selling the assets will be used to fund other growth investments, according to the report.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Nikkei 225TYO:9301
Asia

Viva Leisure Declares Maiden Dividend, Shares Rise 9%

Viva Leisure's (ASX:VVA) board declared a maiden dividend of AU$0.03 per share payable Oct. 20 to shareholders on record as of Sept. 29, according to a Wednesday Australian bourse filing.Its shares rose 9% in recent trading on Wednesday.

ASX:VVA
Asia

ITMAX System Bags New Order Worth MYR187 Million

ITMAX System (KLSE:ITMAX) has secured an order worth 186.8 million ringgit from the Pertubuhan Keselamatan Sosial (Perkeso), according to a Tuesday filing to the Malaysian stock exchange.The company's shares were down over 1% in Wednesday's trade.Under the contract, the company will develop, integrate, deploy, operate and maintain Perkeso's artificial intelligence (AI)-powered employment portal.The contract will be valid for five years starting Sept. 1 to Aug. 31, 2031.

KLSE:ITMAX